Categories
- Indexing & Abstracting
- Editorial Board
- Submit Manuscript
- Instruction to Author
- Current Issue
- Past Issues
- Call for papers/May 2022
- Ethics and Malpractice
- Conflict of Interest Statement
- Statement of Informed Consent
- Final Proof Correction and Submission
- Publication Ethics
- Peer review process
- Cover image - April 2022
- Quick Response - Contact Us
CALL FOR PAPERS
Author Information
CERTIFICATE
IMPACT FACTOR 2019
Subject Area
- Life Sciences / Biology
- Architecture / Building Management
- Asian Studies
- Business & Management
- Chemistry
- Computer Science
- Economics & Finance
- Engineering / Acoustics
- Environmental Science
- Agricultural Sciences
- Pharmaceutical Sciences
- General Sciences
- Materials Science
- Mathematics
- Medicine
- Nanotechnology & Nanoscience
- Nonlinear Science
- Chaos & Dynamical Systems
- Physics
- Social Sciences & Humanities
Why Us? >>
- Open Access
- Peer Reviewed
- Rapid Publication
- Life time hosting
- Free promotion service
- Free indexing service
- More citations
- Search engine friendly
Plagiarism Detection
IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.
Adult orbital rhabdomyosarcoma, a radio-chemosensitivetumour: a case report
Subject Area:
Health Sciences
Abstract:
Introduction: Rhabdomyosarcoma is an extremely aggressive malignant tumor that rarely occurs in adults. Its orbital location represents only 9% of all damage to the head and neck. Case presentation: We report the clinical case of orbital rhabdomyosarcoma in a 23-year-old male patient who presented with progressive right exophthalmos with cervical lymphadenopathy. The introduction of a treatment combining chemotherapy based on ifosfamide, vincristine and actinomycin, and orbital radiotherapy of 66 Gy according to the intensity modulation technique (IMRT), made it possible to obtain a complete remission with a 12 month follow-up. Conclusion: Orbital rhabdomyosarcoma is a rare tumor in adults. Early care improves the vital and functional prognosis.
PDF file:
Announcement
IJMCE RECOMMENDATION
ONLINE PAYPAL PAYMENT
CURRENT ISSUE
NEWS
CHIEF EDITOR
Rosane Cavalcante Fragoso, Brasil
ASSOCIATE CHIEF EDITOR
Jean-Marc SABATIER
Chief Scientific Officer and Head of a Research Group
France
Monthly archive
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- 1 of 5
- ››
Advantages of IJCR
- Rapid Publishing
- Professional publishing practices
- Indexing in leading database
- High level of citation
- High Qualitiy reader base
- High level author suport
Copyright @ 2010 International Journal Of Current Research. All rights reserved
